Investing.com - Zepp Health (NYSE: ZEPP) reported second quarter EPS of ¥-0.1500, ¥0.19 worse than the analyst estimate of ¥0.0400. Revenue for the quarter came in at ¥40.64M versus the consensus estimate of ¥514.77M.
Guidance
Zepp Health sees Q3 2024 revenue of ¥45.0000M-¥60.0000M versus the analyst consensus of ¥102.7000M.
Zepp Health's stock price closed at ¥0.75. It is down -2.6000% in the last 3 months and down -33.6300% in the last 12 months.
Zepp Health saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Zepp Health's stock price’s past reactions to earnings here.
According to InvestingPro, Zepp Health's Financial Health score is "weak performance".
Check out Zepp Health's recent earnings performance, and Zepp Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar